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Microcephalin (MCPH1) is a gene mutated in primary microcephaly, an autosomal recessive neurodevelopmental
disorder in which there is a marked reduction in brain size. PCC syndrome is a recently described disorder of
microcephaly, short stature, and misregulated chromosome condensation. Here, we report the ﬁnding that MCPH1
primary microcephaly and PCC syndrome are allelic disorders, both having mutations in the MCPH1 gene. The
two conditions share a common cellular phenotype of premature chromosome condensation in the early G2 phase
of the cell cycle, which, therefore, appears to be a useful diagnostic marker for individuals with MCPH1 gene
mutations. We demonstrate that an siRNA-mediated depletion of MCPH1 is sufﬁcient to reproduce this phenotype
and also show that MCPH1-deﬁcient cells exhibit delayed decondensation postmitosis. These ﬁndings implicate
microcephalin as a novel regulator of chromosome condensation and link the apparently disparate ﬁelds of neu-
rogenesis and chromosome biology. Further characterization of MCPH1 is thus likely to lead to fundamental insights
into both the regulation of chromosome condensation and neurodevelopment.
Introduction
Primary microcephaly (MIM 251200) is a neurodevel-
opmental disorder characterized by a marked reduction
in brain size in the absence of other malformations or
signiﬁcant neurological deﬁcits. Etiologically, the reduc-
tion in brain size is likely to reﬂect a reduction in neural
cell number, as a consequence of either reduced prolif-
eration or increased cell death (Mochida and Walsh
2001). Primary microcephaly is inherited as an auto-
somal recessive trait and displays genetic heterogeneity,
with six loci mapped to date: MCPH1–MCPH6 (Jack-
son et al. 1998; Jamieson et al. 1999, 2000; Roberts et
al. 1999; Moynihan et al. 2000; Pattison et al. 2000;
Leal et al. 2003). Two genes have been shown to be
mutated in this disorder, microcephalin and ASPM, for
the MCPH1 and MCPH5 loci, respectively (Bond et al.
2002; Jackson et al. 2002). It remains to be determined
how the loss of function of these proteins causes micro-
cephaly. MCPH1 contains several BRCT domains (Huy-
ton et al. 2000) and, therefore, has been hypothesized
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to play a role in cell-cycle regulation or in DNA repair
(Jackson et al. 2002).
Recently, another syndrome of microcephaly, post-
natal short stature and premature chromosome con-
densation syndrome (PCC syndrome [MIM 606858]),
has been described in two children born to consan-
guineous parents (Neitzel et al. 2002). PCC syndrome
has been unique in being the only human disorder in
which chromosome condensation is abnormal. Patients
with this condition have a high number (10%–15%) of
prophase-like cells in routine cytogenetic preparations
and have repeatedly poor-qualitymetaphaseG-banding,
even on high-resolution chromosome preparations. It
has been established that the prophase-like cells result
from the early onset of chromosome condensation
(hence, “premature chromosome condensation”), in an
otherwise apparently unperturbed cell cycle (Neitzel et
al. 2002).
Chromosome condensation is a cellular process that
is essential for the integrity of mitosis and meiosis, re-
quiring both compaction of chromatin and resolution
of intertwined sister chromatids (Swedlow and Hirano
2003). Chromosome compaction requires chromatin re-
organization to achieve a 10,000-fold compression in
the DNA length prior to chromosome segregation. This
is brought about principally by two ATP-hydrolyzing
enzymes—topoisomerase II and the condensin complex.
Resolution also must occur, so that sister chromatids
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Figure 1 Depiction of the 64-cM homozygous region, identiﬁed
by a genomewide search, in consanguineous siblings with PCC syn-
drome. The region of homozygous markers is boxed. Maximum two-
point LOD scores of 1.37 ( ) were obtained for markers D8S264,vp 0
D8S277, D8S550, and D8S560.
are separated from each other, and requires the release
of the cohesin protein complex from chromosomes dur-
ing prophase (Losada et al. 2002). The process of chro-
mosome condensation needs to be regulated appro-
priately, in conjunction with other components of the
cell cycle. Precisely how this is achieved has not been
established yet, although several regulators have been
identiﬁed (Kimura et al. 1998; Losada et al. 2002; Wa-
trin and Legagneux 2003).
We show here that MCPH1 primary microcephaly
and PCC syndrome are allelic conditions. Both are
caused by mutations in the MCPH1 gene and have in
common the cellular phenotype of aberrantly regulated
chromosome condensation.
Subjects and Methods
Subjects
The two families with MCPH1 primary microcephaly
described here have been reported elsewhere (Jackson et
al. 1998, 2002), as has the family with PCC syndrome
(Neitzel et al. 2002). The study was approved by the
Leeds Health Authority/United Leeds Teaching Hospi-
tals National Health Service Trust research ethics com-
mittee and the ethics committee of the Charite´ Univer-
sitary Medicine Berlin, Campus Virchow Hospital.
Cytogenetics
Cytogenetic preparations were performed on periph-
eral blood samples with the use of standard clinical lab-
oratory procedures to prepare G-banded metaphase
spreads (Rooney 2001).
Genetic Linkage Analysis
Microsatellite analysis was performed by standard
semiautomated methods with the use of an ABI PRISM
377 (Applied Biosystems). Markers were selected from
the Ge´ne´thon ﬁnal linkage and Marshﬁeld maps. Two-
point LOD scores were calculated with LINKAGE v5.2
(Lathrop and Lalouel 1984).
Mutation Detection
The entire coding region of the MCPH1 gene was
screened by direct sequencing, as described elsewhere
(Jackson et al. 2002). Speciﬁcally, exon 5 was ampliﬁed
by PCR and was sequenced with primers ex5F, dTGCC-
TTAAGCAGTTGCAGGAC, and ex5R, dACCCCACT-
AGTCATCATGCAAA. Sequencing was performed us-
ing Big Dye Terminator cycle sequencing kit (Applied
Biosystems), in accordance with the manufacturer’s pro-
tocol, and electrophoresis was done with an ABI 377
gene sequencer.
siRNA-Mediated Depletion of MCPH1
Cells were transfected with 110 nM of RNA duplexes
(Qiagen-Xeragon) with the use of Oligofectamine (In-
vitrogen), in accordance with themanufacturer’s instruc-
tions. The siRNA duplex sense-strand sequences were
the MCPH1-derived sequence, 5′-CUCUCUGUGUGA-
AGCACCA-3′, and the control sequence, 5′-UUCUCCG-
AACGUGUCACGU-3′. Chromosome preparation was
performed 48 h after transfection, with the use of stan-
dard methods, and 11,000 nuclei per preparation were
scored. Transfection efﬁciency was estimated at 70%–
80% by counting the proportion of ﬂuorescent cells after
treatment with the ﬂuorescein-conjugated control duplex.
Cytochalasin-B Block to Demonstrate Decondensation
Delay
Cytokinesis was blocked with 6 mg/ml of cytochalasin,
6 h before harvesting. Cells were subjected to hypotonic
treatment with 0.075 M of KCl for 2 min and were ﬁxed
two times with a 3:1 mix of methanol and acetic acid,
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Figure 2 Findings indicating that MCPH1 primary microcephaly and PCC syndrome are allelic disorders. Patients with MCPH1 primary
microcephaly (black diamonds) and patients with PCC syndrome (unblackened squares) have a similar degree of microcephaly, and both groups
also exhibit short stature of varying severity. a, Head circumference (OFC), height, and weight, plotted as SDs relative to the appropriate age-
and sex-related population mean. b and c, Neuroimaging in MCPH1 primary microcephaly, demonstrating a small but structurally normal
brain. In PCC syndrome, however, there is more marked gyral simpliﬁcation resembling pachygyria (d), and periventricular neuronal heterotopias
are also present (e). Subjects include an adult with MCPH1 primary microcephaly (b, T1W sagittal; c, axial T2W) and an 18-mo–old child
with PCC syndrome (d, axial T2W; e, axial T1W and T2W images of lateral ventricles). f–h, MRI scans of normal subjects age matched to
those of images b–d, respectively. The scale bar is 1 cm.
Figure 3 Premature chromosome condensation, present in both
MCPH1 primary microcephaly and PCC syndrome. Shown are pro-
phase-like cells in peripheral blood lymphocytes of patientswithMCPH1
primary microcephaly (a) and patients with PCC syndrome (b).
and the last ﬁxation was in a 9:1 mix of methanol and
glacial acetic acid. Nuclei were stained with Giemsa.
Results
Genomewide homozygosity mapping of the family with
PCC syndrome had identiﬁed a single large candidate
region of 64 cM on chromosome 8 (markers D8S264–
D8S532), which included theMCPH1 locus (ﬁg. 1). This
ﬁnding and an overlapping clinical phenotype (ﬁg. 2) led
us to consider the possibility that these two disorders
might be allelic. Severe microcephaly is present in both
MCPH1 primary microcephaly (5 to 10 SD) and
PCC syndrome (8 to 10 SD) (ﬁg. 2a). A variable
short stature is also evident in both. Magnetic resonance
imaging (MRI) demonstrates a marked reduction in the
size of the cerebral cortex, as well as some reduction in
cerebellar and brain-stem volume (ﬁg. 2b–2d). Overall,
the neuroimaging is consistent with the classiﬁcation
“microcephaly with simpliﬁed gyri” type I (Dobyns
2002). However, in patients with PCC syndrome, per-
iventricular neuronal heterotopias were also observed
(ﬁg. 2e), as well as a marked gyral simpliﬁcation giving
the appearance of pachygyria (ﬁg. 2d).
To investigate whether individuals with MCPH1 pri-
mary microcephaly showed evidence of the PCC cellular
phenotype, archival G-banded cytogenetic preparations
of peripheral blood lymphocytes were reviewed. Pre-
vious laboratory reports from these patients, indicating
low-quality metaphases with poor banding resolution,
were conﬁrmed. However, multiple prophase-like cells
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Figure 4 Homozygous ins427A mutation (arrow) of the
MCPH1 gene, which is present in patients with PCC syndrome.
Figure 5 The siRNA-mediated depletion of MCPH1 is sufﬁcient to cause premature chromosome condensation. a, Prophase-likephenotype
observed in HeLa cells after siRNA-mediated depletion of MCPH1. A marked increase in prophase cells is seen after MCPH1 siRNA transfection
in HeLa and LN9SV ﬁbroblasts (b), whereas there is no signiﬁcant change in mitotic index (% metaphases) (c).
were also identiﬁed, representing 7%–17% of the total
number of cells. These prophase-like cells were identical
in morphology to those seen previously in PCC syn-
drome (ﬁg. 3).
Sequencing the entire coding sequence of the MCPH1
gene in patients with PCC syndrome revealed a single-
nucleotide insertion in exon 5 within an A6 run (coding
nt 427) (ﬁg. 4). The resulting frameshift is predicted to
generate a termination codon in exon 6 and, thus, a
markedly truncated protein of 146 aa, encoding only
the N-terminal BRCT domain of the MCPH1 protein.
This sequence change was homozygous in both affected
children, heterozygous in both parents, and not present
in 220 control alleles.
Next, RNAi depletion of MCPH1 was performed to
conﬁrm that loss of microcephalin function is sufﬁcient
to induce the cellular phenotype of PCC. Both HeLa
and SV40-transformed ﬁbroblast (LN9SV) cell lines,
transfected with an siRNA duplex speciﬁc for MCPH1,
manifested a cellular phenotype identical to that seen
in affected individuals (ﬁg. 5). Cell counts demonstrated
that signiﬁcantly more prophase-like cells ( , x2)P K .001
were present in both cell lines treated with the MCPH1
siRNA than in cells treated with the control duplex (ﬁg.
5b and 5c). Thus, we infer that the cellular phenotype
observed in patients is due to functional loss of the
microcephalin protein.
Reviewing diagnostic cytogenetic slides, we observed
smaller nuclei with a PCC phenotype, which raised the
possibility that such cells might represent postmitotic
cells that have not yet decondensed their chromatin. To
address this hypothesis, lymphoblastoid cell lines from
both patients with MCPH1 primary microcephaly and
those with PCC syndrome were treated with cytochal-
asin B. By preventing cytokinesis, this treatment enables
postmitotic cells to be distinguished by their binucleate
nature. Many early-G1 binucleate cells from patients
with MCPH1 primary microcephaly and from those
with PCC syndrome had condensed chromosomes 6 h
after treatment, a ﬁnding not present in controls (P K
, x2) (ﬁg. 6). From this, we infer that there is also.001
a considerable delay in chromosome decondensation af-
ter mitosis in early G1.
Discussion
We establish here that mutations in the MCPH1 gene
are the cause of both PCC syndrome and MCPH1 pri-
mary microcephaly. Diagnostically, the PCC condensa-
tion phenotype may prove to be a cytogenetic hallmark
for these disorders, and the presence of prophase cells
should have considerable diagnostic utility in the iden-
tiﬁcation of individuals with MCPH1 mutations. Mu-
tation screening of future patients with “PCC” cellular
phenotype will be required to establish whether this
phenotype is always the result of MCPH1 mutations or
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Figure 6 Delayed decondensation observed in MCPH1-deﬁcient cells. a, Binucleate MCPH1 mutant cell with condensed chromosomes
indicating a delay in decondensation. b, Binucleate control lymphoblastoid cell with decondensed chromatin. c, Proportion of cells with condensed
chromosomes postmitosis in patient and control cell lines. Many cytochalasin-treated binucleate G1-phase PCC (29%) and MCPH1 (36%)
mutant cells show condensed chromatin, compared with control lymphoblastoid cells (4%).
whether other genes also might be implicated in this
process.
Our results implicate microcephalin as a regulator
of chromosome condensation in both the G2 and G1
phases of the cell cycle. This ﬁnding reinforces the hy-
pothesis that MCPH1 primary microcephaly is due to
perturbation of the cell cycle during neurogenesis, re-
sulting in either reduced proliferative capacity or in-
creased cell death. Surprisingly, however, we ﬁnd that
neuronal heterotopias sometimes can be found also in
individuals with MCPH1mutations, suggesting thatmi-
gration of neurons and glia during formation of the
cerebral cortex (Barkovich et al. 2001) might be per-
turbed. This observation raises interesting questions re-
garding the possible extension of the MCPH1 primary
microcephaly phenotype into neuronal heterotopia and
other neuronal migration disorders.
Our ﬁndings have important implications for the cell
biology of chromosome condensation and its regu-
lation. Topoisomerase II and the condensin complex
are key components in compacting chromatin intomet-
aphase chromosomes, whereas sister chromatid res-
olution follows the release of cohesin from chromatin
(Swedlow and Hirano 2003). However, regulation of
these processes is incompletely understood. Chromatin
compaction is, at least in part, controlled by loading of
condensin onto chromatin. In turn, condensin function
may be regulated by phosphorylation involving distinct
signaling elements that include Cdk1 and Aurora B (Ki-
mura et al. 1998; Swedlow and Hirano 2003). The ab-
normally early compaction of chromatin in MCPH1-
deﬁcient cells could indicate that MPCH1 negatively
regulates condensin loading, and it will be important to
deﬁne its relationship to condensin and these regulators.
However, compaction is not entirely dependent on con-
densin, since removing condensin subunits in several
model organisms perturbs, but does not prevent, chro-
mosome condensation (Swedlow and Hirano 2003;
Watrin and Legagneux 2003). Additionally, condensin
loading onto chromosomes appears to occur during late
prophase, well after the visible chromosome conden-
sation is apparent (Watrin and Legagneux 2003), which
indicates that other factors, perhaps including MCPH1,
also must participate in chromatin compaction and its
regulation.
In summary, our earlier ﬁnding of abnormal chro-
mosome condensation in early G2 phase (Neitzel et al.
2002) is shown now to result from the absence of func-
tional microcephalin. This implicates MCPH1 as a neg-
ative regulator of chromosome condensation, acting
very early in the condensation process, quite possibly
prior to the involvement of condensin. Homology of
microcephalin with cell-cycle checkpoint proteins, such
as BRCA1 and TopBP1, which regulate G2/M transi-
tion, may indicate that it acts as an intermediary be-
tween the cell cycle control and chromosome conden-
sation apparatus. Additionally, the ﬁnding of delayed
chromosome decondensation in mutant cell lines im-
plies that postmitotic decondensation is also a regulated
and active process. Further biochemical characteriza-
tion of microcephalin thus promises to provide impor-
tant new insights into the regulation of both conden-
sation and decondensation of mitotic chromosomes.
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